Literature DB >> 20393490

LECT2 amyloidosis.

Merrill D Benson1.   

Abstract

LECT2 amyloidosis is the latest systemic type of amyloidosis to be described. It was discovered in patients with nephrotic syndrome and renal failure and is characterized by amyloid deposition in glomeruli, renal vessels, and interstitium. Clinical and pathological features of earlier phases of this type of amyloidosis have yet to be determined.

Entities:  

Mesh：

Year:  2010        PMID： 20393490     DOI： 10.1038/ki.2010.18

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  4 in total

Review 1.  Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics.

Authors:  Samih H Nasr; Ahmet Dogan; Christopher P Larsen
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-14       Impact factor: 8.237

2.  Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice.

Authors:  Akinori Okumura; Takeshi Saito; Minoru Tobiume; Yuki Hashimoto; Yuko Sato; Takashi Umeyama; Minoru Nagi; Koichi Tanabe; Hiroyuki Unoki-Kubota; Yasushi Kaburagi; Hideki Hasegawa; Yoshitsugu Miyazaki; Satoshi Yamagoe
Journal:  Biochem Biophys Rep       Date:  2017-10-13

3.  Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: A case report.

Authors:  Hongzhao Xu; Ye Jia; Xueyao Wang; Hui Wang; Jinyu Yu; Wu Hao
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

4.  Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.

Authors:  Steven Law; Julian Gillmore; Janet A Gilbertson; Paul Bass; Alan D Salama
Journal:  BMC Nephrol       Date:  2020-02-28       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.